PDCD1 and neoplasm: In the TC-1 mouse model, an increase was observed in tumor clearance from 40% (4/10) with HB-201 alone to 78% (7/9) with HB-201 plus PD-1 inhibitor, suggesting that this combination has the potential to act synergistically and improve long-term outcomes.